Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart BDR | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$4.37T | 39x | 1.01 | R$34.26 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kroger Co | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$237.78B | 16.7x | 6.05 | R$354.55 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sysco | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$209.59B | 22.1x | -5.19 | R$220 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano DRC | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$167.80B | 35.2x | -1.34 | R$513.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RAIADROGASIL ON | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$31.55B | 25x | 1.25 | R$18.42 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14% Upside | Upgrade to Pro+ | |
Grupo Mateus | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$15.62B | 11.2x | 0.91 | R$6.95 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.5% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$12.82B | 15.1x | 0.35 | R$9.51 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.6% Upside | Upgrade to Pro+ | |
Pague Menos | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$2.23B | 40x | -0.84 | R$3.60 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.7% Upside | Upgrade to Pro+ | |
Brasileira De Dist | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.95B | -1.5x | -0.03 | R$3.98 | -8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -24.6% Downside | Upgrade to Pro+ | |
Dimed | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$1.46B | 12.5x | 0.45 | R$9.77 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.8% Upside | Upgrade to Pro+ | |
D1000 On | B3 | Consumer Non-Cyclicals | Food & Drug Retailing | R$253.01M | 12.4x | -0.46 | R$5 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44% Upside | Upgrade to Pro+ |